Navigation Links
PharmAthene to Present at the BIO CEO & Investor Conference 2008
Date:2/6/2008

ANNAPOLIS, Md., Feb. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: PIP) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that David P. Wright, President and Chief Executive Officer of PharmAthene, will present at the BIO CEO & Investor Conference 2008, in New York, NY on Wednesday, February 13, 2008 at 2:00 p.m. The presentation is scheduled to take place in the Basildon Room at the Waldorf Astoria Hotel.

PharmAthene's presentation will be available via webcast on the company's website at http://www.pharmathene.com. A link to access the webcast will be accessible from both the homepage and the investor relations pages of the PharmAthene corporate website. For assistance, contact Stacey Jurchison at 410-269-2610.

About PharmAthene, Inc.

PharmAthene (Amex: PIP) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead programs include Valortim(TM) for the prevention and treatment of anthrax infection and Protexia(R) for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents. For more information on PharmAthene, please visit http://www.pharmathene.com.


'/>"/>
SOURCE PharmAthene Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
6. Avicena Group to Present at Noble Financial Conference
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. CEL-SCI to Present at the Noble Financial Conference
11. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2020)... Texas (PRWEB) , ... March 30, 2020 , ... ... (APMD) and telehealth developer Reliant Immune Diagnostics (RID), formed earlier this year to ... COVID-19 pandemic by creating in-home tests for COVID-19. Company officials are currently?awaiting an ...
(Date:3/27/2020)... ... , ... iFirst Medical Technologies, Inc., a leader in handheld diagnostic devices, announced ... poses a grave danger to public health here in the U.S. and around the ... Broad-based testing and on-the-spot results promise to slow the spread and save human lives." ...
(Date:3/10/2020)... ... March 10, 2020 , ... Ortho Clinical Diagnostics, a global leader of in ... ORTHOTM Sera, ID-MTS, a suite of extended antigen in a gel testing format used ... ORTHO VISION® and ORTHO VISION® Max in the United States and Canada. The clearances ...
(Date:3/3/2020)... (PRWEB) , ... March 03, 2020 , ... ... serving the pharmaceutical, biotech and medical device industries, was recognized by INC. 5,000 ... puts forward annual lists to note industry leaders greatly impacting their spheres of ...
Breaking Biology Technology:
(Date:3/9/2020)... (PRWEB) , ... March 09, ... ... enterprises witnessed a steep growth rate of 64% last year, as enterprises ... new research from Everest Group. Unfortunately, only 13% of all transformation efforts ...
(Date:3/5/2020)... ... March 05, 2020 , ... ... formation of its Scientific Advisory Board (SAB) comprised of the industry’s key ... centers, cell therapy centers, and private industry. Cytonus is a leading cell-based ...
(Date:3/5/2020)... ... 05, 2020 , ... Diagenode, a leading global provider of ... subsidiary of global genomics leader BGI Group, today announced a co-marketing agreement for ... Asia Pacific. , Under the terms of the non-exclusive agreement, the two ...
Breaking Biology News(10 mins):